Q2 revenues were slightly better than expected, up by 2.6% yoy and lfl while the EBITDA was more in line with expectations, up by 1% yoy and lfl. The only weak point of the release was the expected pronounced decline in the Enterprise EBITDAaL which should only improve from 2024. The clear positive is that, in 2022, the group entered a virtuous circle of vigorous FCF growth for the coming years. We maintain our strong buy on the stock.